22 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32953793 | Estrogen receptor α is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer. | 2020 Aug | 2 |
2 | 33209217 | Effect of 5-aza-2'-deoxycytidine on Estrogen Receptor Alpha/Beta and DNA Methyltransferase 1 Genes Expression, Apoptosis Induction, and Cell Growth Prevention of the Colon Cancer HT 29 Cell Line. | 2020 | 2 |
3 | 30593524 | Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis. | 2019 Mar 15 | 3 |
4 | 28108626 | A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes. | 2017 Feb | 1 |
5 | 27159275 | A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells. | 2016 | 1 |
6 | 25927974 | Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues. | 2015 May 1 | 4 |
7 | 24924415 | Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells. | 2014 Jul | 2 |
8 | 23810988 | Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells. | 2013 Aug 15 | 1 |
9 | 21515334 | Suppression of WIF-1 through promoter hypermethylation causes accelerated proliferation of the aryl hydrocarbon receptor (AHR) overexpressing MCF10AT1 breast cancer cells. | 2011 Jul 29 | 1 |
10 | 19148464 | Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. | 2009 Feb | 1 |
11 | 19458056 | Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure. | 2009 Jun 1 | 4 |
12 | 18264725 | ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor. | 2008 Aug | 10 |
13 | 18317449 | Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells. | 2008 Jul 3 | 1 |
14 | 17533738 | [Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast]. | 2006 Dec | 7 |
15 | 15767557 | Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells. | 2005 Mar | 2 |
16 | 16412295 | [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro]. | 2005 Dec 1 | 1 |
17 | 11309276 | Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer. | 2001 Apr 15 | 1 |
18 | 11488527 | Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. | 2001 Jul | 1 |
19 | 11585728 | Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. | 2001 Oct 1 | 2 |
20 | 10676656 | Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression. | 2000 Feb 1 | 2 |
21 | 9632722 | Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine. | 1998 Jun 26 | 1 |
22 | 9405430 | Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells. | 1997 Dec 19 | 3 |